Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 3Recruiting 2Not yet recruiting 2Completed 2Active not recruiting 2Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Thyroid Nodule 1Thyroid Neoplasms 1Neoplastic Cells, Circulating 1Lung Neoplasms 1Disease 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 84Cisplatin 79Pemetrexed 72Docetaxel 62Drug Therapy 44Gemcitabine 43Erlotinib Hydrochloride 42Gefitinib 38Radiotherapy 36Paclitaxel 36pembrolizumab 31Bevacizumab 29icotinib 28osimertinib 27anlotinib 26Nivolumab 26camrelizumab 23Vinorelbine 23Radiosurgery 20aumolertinib 18atezolizumab 17sintilimab 16apatinib 16Endostatins 16endostar protein 15durvalumab 14Surgical Procedures, Operative 13Immunotherapy 13Immune Checkpoint Inhibitors 12Blood Specimen Collection 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Non-Small-Cell Lung × Anterior Temporal Lobectomy × Clear all
NCT03108560 2018-09-07

Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer

Shanghai Zhongshan Hospital

Phase NA Unknown
600 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡